| Thymosin α 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling L Romani, F Bistoni, R Gaziano, S Bozza, C Montagnoli, K Perruccio, ... Blood 103 (11), 4232-4239, 2004 | 275 | 2004 |
| Nanopore technology for biomedical applications TA Desai, DJ Hansford, L Kulinsky, AH Nashat, G Rasi, J Tu, Y Wang, ... Biomedical Microdevices 2, 11-40, 1999 | 251 | 1999 |
| From adaptive licensing to adaptive pathways: delivering a flexible life‐span approach to bring new drugs to patients HG Eichler, LG Baird, R Barker, B Bloechl‐Daum, F Børlum‐Kristensen, ... Clinical Pharmacology & Therapeutics 97 (3), 234-246, 2015 | 248 | 2015 |
| Thymosin α1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance L Romani, F Bistoni, K Perruccio, C Montagnoli, R Gaziano, S Bozza, ... Blood 108 (7), 2265-2274, 2006 | 213 | 2006 |
| Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update JL Brozek, CE Baena‐Cagnani, S Bonini, GW Canonica, G Rasi, ... Allergy 63 (1), 38-46, 2008 | 199 | 2008 |
| Stimulatory effect of Eucalyptus essential oil on innate cell-mediated immune response A Serafino, PS Vallebona, F Andreola, M Zonfrillo, L Mercuri, M Federici, ... BMC immunology 9, 1-16, 2008 | 186 | 2008 |
| The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation A Serafino, E Balestrieri, P Pierimarchi, C Matteucci, G Moroni, E Oricchio, ... Experimental cell research 315 (5), 849-862, 2009 | 165 | 2009 |
| Drug policy for an aging population—the European Medicines Agency's geriatric medicines strategy F Cerreta, HG Eichler, G Rasi New England Journal of Medicine 367 (21), 1972-1974, 2012 | 161 | 2012 |
| Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN S Bonini, M Bonini, J Bousquet, V Brusasco, GW Canonica, KH Carlsen, ... Allergy 61 (6), 681-692, 2006 | 160 | 2006 |
| Nerve growth factor: neurotrophin or cytokine? S Bonini, G Rasi, ML Bracci-Laudiero, A Procoli, L Aloe International archives of allergy and immunology 131 (2), 80-84, 2003 | 147 | 2003 |
| Thymosin α1: an endogenous regulator of inflammation, immunity, and tolerance L Romani, F Bistoni, C Montagnoli, R Gaziano, S Bozza, P Bonifazi, ... Annals of the New York Academy of Sciences 1112 (1), 326-338, 2007 | 145 | 2007 |
| AQUA: allergy questionnaire for athletes. Development and validation M Bonini, F Braido, I Baiardini, S Del Giacco, C Gramiccioni, M Manara, ... Med Sci Sports Exerc 41 (5), 1034-41, 2009 | 133 | 2009 |
| Randomized controlled trials versus real world evidence: neither magic nor myth HG Eichler, F Pignatti, B Schwarzer‐Daum, A Hidalgo‐Simon, I Eichler, ... Clinical Pharmacology & Therapeutics 109 (5), 1212-1218, 2021 | 126 | 2021 |
| Time to review the role of surrogate end points in health policy: state of the art and the way forward O Ciani, M Buyse, M Drummond, G Rasi, ED Saad, RS Taylor Value in Health 20 (3), 487-495, 2017 | 126 | 2017 |
| Open clinical trial data for all? A view from regulators HG Eichler, E Abadie, A Breckenridge, H Leufkens, G Rasi PLoS medicine 9 (4), e1001202, 2012 | 125 | 2012 |
| The risks of risk aversion in drug regulation HG Eichler, B Bloechl-Daum, D Brasseur, A Breckenridge, H Leufkens, ... Nature reviews Drug discovery 12 (12), 907-916, 2013 | 120 | 2013 |
| Data rich, information poor: can we use electronic health records to create a learning healthcare system for pharmaceuticals? HG Eichler, B Bloechl‐Daum, K Broich, PA Kyrle, J Oderkirk, G Rasi, ... Clinical Pharmacology & Therapeutics 105 (4), 912-922, 2019 | 108 | 2019 |
| Microfabricated biocapsules provide short-term immunoisolation of insulinoma xenografts TA Desai, WH Chu, G Rasi, P Sinibaldi-Vallebona, E Guarino, M Ferrari Biomedical microdevices 1, 131-138, 1999 | 104 | 1999 |
| Thymosin α1 in combination with cytokines and chemotherapy for the treatment of cancer E Garaci, F Pica, P Sinibaldi-Vallebona, P Pierimarchi, A Mastino, ... International immunopharmacology 3 (8), 1145-1150, 2003 | 99 | 2003 |
| Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application E Garaci, F Pica, G Rasi, C Favalli International Journal of Immunopharmacology 22 (12), 1067-1076, 2000 | 96 | 2000 |
